Related references
Note: Only part of the references are listed.The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
Sujay Paul et al.
VIRUS RESEARCH (2022)
COVID-19: fighting the invisible enemy with microRNAs
Neeraj Chauhan et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)
Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
Hongpeng Jia et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2021)
MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?
Farshad Abedi et al.
CELL CYCLE (2021)
Expression and co-expression analyses of TMPRSS2, a key element in COVID-19
Francesco Piva et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)
Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
Laura Kate Gadanec et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium
Bryce A. Schuler et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation
Mohamed M. Aboudounya et al.
MEDIATORS OF INFLAMMATION (2021)
Kidney injury molecule-1 is a potential receptor for SARS-CoV-2
Chen Yang et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2021)
Kidney injury molecule-1: a novel entry factor for SARS-CoV-2
Cheng Wan et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2021)
No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor
Jarrod Shilts et al.
SCIENTIFIC REPORTS (2021)
COVID-19 and SARS-CoV-2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease
Periklis Katopodis et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)
Determining available strategies for prevention and therapy: Exploring COVID-19 from the perspective of ACE2 (Review)
Liyang Cai et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)
SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development
Nicholas Murgolo et al.
PLOS PATHOGENS (2021)
A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples
Taruna Madan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2021)
SARS-CoV-2 spike protein interacts with and activates TLR41
Yingchi Zhao et al.
CELL RESEARCH (2021)
The role of miRNAs in COVID-19 disease
Mona Fani et al.
FUTURE VIROLOGY (2021)
Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage
Stefanie Deinhardt-Emmer et al.
ELIFE (2021)
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Marcin F. Osuchowski et al.
LANCET RESPIRATORY MEDICINE (2021)
Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles
Miao-Hsi Hsieh et al.
FRONTIERS IN IMMUNOLOGY (2021)
Serum surfactant protein D in COVID-19 is elevated and correlated with disease severity
Ming Tong et al.
BMC INFECTIOUS DISEASES (2021)
A cohort autopsy study defines COVID-19 systemic pathogenesis
Xiao-Hong Yao et al.
CELL RESEARCH (2021)
AGTR2, One Possible Novel Key Gene for the Entry of SARS-CoV-2 Into Human Cells
Chunmei Cui et al.
IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS (2021)
A brief molecular insight of COVID-19: epidemiology, clinical manifestation, molecular mechanism, cellular tropism and immuno-pathogenesis
Sweta Singh et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
Post-Mortem Detection of SARS-CoV-2 RNA in Long-Buried Lung Samples
Nicolo Musso et al.
DIAGNOSTICS (2021)
Therapeutic Significance of microRNA-Mediated Regulation of PARP-1 in SARS-CoV-2 Infection
Sabyasachi Dash et al.
NON-CODING RNA (2021)
SARS-CoV-2 encoded microRNAs are involved in the process of virus infection and host immune response
Zhi Liu et al.
JOURNAL OF BIOMEDICAL RESEARCH (2021)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
COVID-19 spike-host cell receptor GRP78 binding site prediction
Ibrahim M. Ibrahim et al.
JOURNAL OF INFECTION (2020)
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs
Abhigyan Choudhury et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-Converting Enzyme 2 as a Potential Drug Target - A Perspective
Thea Magrone et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
ADAM17 inhibition may exert a protective effect on COVID-19
Vanesa Palau et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
Ruochen Zang et al.
SCIENCE IMMUNOLOGY (2020)
New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
Yuan Hou et al.
BMC MEDICINE (2020)
Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract
Jaewon J. Lee et al.
GENES (2020)
Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19
Md. Abdullah-Al-Kamran Khan et al.
FRONTIERS IN GENETICS (2020)
MicroRNAs: From Mechanism to Organism
Philipp J. Dexheimer et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2
Stepan Nersisyan et al.
PLOS ONE (2020)
Neuropilin-1 is a host factor for SARS-CoV-2 infection
James L. Daly et al.
SCIENCE (2020)
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti-Castelvetri et al.
SCIENCE (2020)
ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
Donato Zipeto et al.
FRONTIERS IN IMMUNOLOGY (2020)
Identification of Novel Hypothalamic MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating ACE2 and TMPRSS2 Expression: An In Silico Analysis
Debasmita Mukhopadhyay et al.
BRAIN SCIENCES (2020)
SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses
Abdo A. Elfiky
FRONTIERS IN PHARMACOLOGY (2020)
ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors
Zofia Wicik et al.
JOURNAL OF CLINICAL MEDICINE (2020)
ACE2 partially dictates the host range and tropism of SARS-CoV-2
Shan Gao et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
miRNA target prediction might explain the reduced transmission of SARS-CoV-2 in Jordan, Middle East
Hazem Haddad et al.
NON-CODING RNA RESEARCH (2020)
Renal complications in coronavirus disease 2019: a systematic review
Taichiro Minami et al.
INFLAMMATION AND REGENERATION (2020)
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
Ke Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Natalia Zamorano Cuervo et al.
ELIFE (2020)
Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro
Qi Zhang et al.
CELL DISCOVERY (2020)
miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19
Alessandro Matarese et al.
BIOMEDICINES (2020)
MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
Dongchao Lu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19
Jonathan H. Shrimp et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies
Rahila Sardar et al.
HELIYON (2020)
Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer
Juhi Kumar et al.
FRONTIERS IN ONCOLOGY (2019)
Deciphering miRNAs' Action through miRNA Editing
Marta Correia de Sousa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The role of MicroRNAs in human cancer
Yong Peng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
miRDB: an online resource for microRNA target prediction and functional annotations
Nathan Wong et al.
NUCLEIC ACIDS RESEARCH (2015)
TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
Adeline Heurich et al.
JOURNAL OF VIROLOGY (2014)
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
Ilona Glowacka et al.
JOURNAL OF VIROLOGY (2011)
A Brief Review on the Mechanisms of miRNA Regulation
Yimei Cai et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2010)
miRDB: A microRNA target prediction and functional annotation database with a wiki interface
Xiaowei Wang
RNA (2008)
The evolution of gene regulation by transcription factors and microRNAs
Kevin Chen et al.
NATURE REVIEWS GENETICS (2007)
Tumor necrosis factor-α convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)
DW Lambert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
Share Paper
